Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 581

Similar articles for PubMed (Select 10496449)

2.

Secondary prevention in a cardiology group practice and hospital setting after a heart-care initiative.

LaBresh KA, Owen P, Alteri C, Reilly S, Albright PS, Hordes AR, Shaftel PA, Noonan TE, Stoukides CA, Kaul AF.

Am J Cardiol. 2000 Feb 10;85(3A):23A-29A.

PMID:
10695704
3.

Diet and coronary heart disease: a review of the committee of diet and heart disease of the National Heart Foundation of Australia.

[No authors listed]

Med J Aust. 1979 Sep 22;2(6):294-307. Review. No abstract available.

PMID:
392275
4.

Does hypolipidemic therapy prevent coronary heart disease?

Rifkind BM, Levy RI.

Cardiovasc Clin. 1974;6(2):1-8. Review. No abstract available.

PMID:
4374303
5.

Management of dyslipidemia.

Akel MM, Salti I.

J Med Liban. 2001 Sep-Oct;49(5):274-8. No abstract available.

PMID:
12243421
6.

[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].

Dobordzhginidze LM.

Kardiologiia. 2004;44(3):87-93. Review. Russian. No abstract available.

PMID:
15489838
7.

Effects of intensive diet and exercise intervention in patients taking cholesterol-lowering drugs.

Barnard RJ, DiLauro SC, Inkeles SB.

Am J Cardiol. 1997 Apr 15;79(8):1112-4.

PMID:
9114776
8.

Cholesterol and coronary artery disease--issues in the 1990s.

Chia BL.

Singapore Med J. 1991 Oct;32(5):291-4. No abstract available.

PMID:
1788566
9.

Aggressive medical therapy for the prevention and treatment of coronary artery disease.

Malloy MJ, Kane JP.

Dis Mon. 1998 Jan;44(1):1-40. Review. No abstract available.

PMID:
9457050
10.
11.

The lipid management nutrition outcomes project: perspectives from a national experience in protocol implementation and nutrition outcomes tracking.

Rhodes KS, Weintraub MS, Biesemeier CK, Rubenfire M.

J Am Diet Assoc. 2008 Feb;108(2):332-9. doi: 10.1016/j.jada.2007.10.048.

PMID:
18237579
13.

Lipids and prevention in coronary care.

Betteridge DJ.

Trans Med Soc Lond. 1994-1995;111:43-58. No abstract available.

PMID:
9156156
14.

Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction.

Gotto AM Jr.

Am J Cardiol. 1998 Nov 5;82(9A):1Q-2Q. Review. No abstract available.

PMID:
9819097
15.

Dyslipidemia and coronary heart disease: management issues from Indian perspective.

Gambhir DS, Gambhir JK, Sudha R.

Indian Heart J. 2000 Sep-Oct;52(5):515-6, 617. Review. No abstract available.

PMID:
11256772
16.

Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.

Mosca L, Merz NB, Blumenthal RS, Cziraky MJ, Fabunmi RP, Sarawate C, Watson KE, Willey VJ, Stanek EJ.

Circulation. 2005 Feb 1;111(4):488-93.

17.

[Changes of risk factors in patients with coronary heart disease after in-patient rehabilitation].

Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H.

Dtsch Med Wochenschr. 2003 Jul 11;128(28-29):1525-30. German.

PMID:
12854061
18.

Hyperlipidaemia management after primary coronary artery bypass surgery: a survey of patients and general practitioners.

Goldsmith I, Lip GY, Emsden K, Nugent A, Patel RL.

J Cardiovasc Risk. 1999 Aug;6(4):263-7.

PMID:
10501279
19.

Lipoprotein analysis.

Colyar MR.

Adv Nurse Pract. 2002 May;10(5):30-2. No abstract available.

PMID:
12420528
20.

[Therapeutic management of the dyslipidemic patient].

Agence Française de Sécurité Sanitaire des Produits de Santé.

Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 1):70-5. French. No abstract available.

PMID:
11240406
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk